Q1 2023 Holdings
Filed 2023-05-15 | 58 holdings | $3.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $561.5M | 11,584,280 | 18.1% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $413.4M | 2,999,453 | 13.3% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $359.6M | 5,451,647 | 11.6% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $164.0M | 4,244,645 | 5.3% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $163.7M | 7,521,024 | 5.3% |
| Xencor Inc(XNCR) | COM | 98401F105 | $147.3M | 5,282,516 | 4.7% |
| Morphic Hldg Inc | COM | 61775R105 | $144.8M | 3,846,966 | 4.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $115.9M | 5,352,183 | 3.7% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $112.8M | 5,991,479 | 3.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $101.6M | 3,717,788 | 3.3% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $91.2M | 10,087,473 | 2.9% |
| Springworks Therapeutics Inc | COM | 85205L107 | $89.1M | 3,460,208 | 2.9% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $81.2M | 6,638,371 | 2.6% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $68.6M | 4,163,824 | 2.2% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $46.4M | 3,838,486 | 1.5% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $29.7M | 3,851,507 | 1.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $26.8M | 2,322,384 | 0.9% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $26.3M | 6,435,518 | 0.8% |
| Alector Inc(ALEC) | COM | 014442107 | $25.1M | 4,056,548 | 0.8% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $23.6M | 796,093 | 0.8% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $23.3M | 3,493,194 | 0.8% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $23.1M | 13,896,543 | 0.7% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $22.2M | 4,488,200 | 0.7% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $21.6M | 5,618,779 | 0.7% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $21.4M | 1,330,263 | 0.7% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $20.9M | 8,538,446 | 0.7% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $20.7M | 6,184,861 | 0.7% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $20.5M | 3,560,700 | 0.7% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $19.5M | 3,418,068 | 0.6% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $16.6M | 4,201,414 | 0.5% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $15.8M | 6,117,400 | 0.5% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $10.3M | 445,550 | 0.3% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $8.4M | 1,956,579 | 0.3% |
| Poseida Therapeutics Inc(PSTXUSD) | COM | 73730P108 | $8.2M | 2,650,000 | 0.3% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $7.4M | 1,802,122 | 0.2% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $7.4M | 600,000 | 0.2% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $6.2M | 2,902,715 | 0.2% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $6.1M | 198,591 | 0.2% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $4.6M | 415,322 | 0.1% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $4.4M | 619,192 | 0.1% |
| Aligos Therapeutics Inc | COM | 01626L105 | $3.5M | 3,948,360 | 0.1% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $2.5M | 246,410 | 0.1% |
| Tempest Therapeutics Inc(OVASUSD) | COM | 87978U108 | $2.4M | 1,031,268 | 0.1% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $2.3M | 1,191,094 | 0.1% |
| Surface Oncology Inc | COM | 86877M209 | $2.2M | 3,082,959 | 0.1% |
| Erasca Inc(ERAS) | COM | 29479A108 | $2.0M | 678,441 | 0.1% |
| Eucrates Biomedical Acqu COR | SHS | G3141W106 | $2.0M | 200,000 | 0.1% |
| Hookipa Pharma Inc | COM | 43906K100 | $1.8M | 2,473,489 | 0.1% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $1.6M | 963,333 | 0.1% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $1.5M | 798,948 | 0.0% |